Novartis Announces Intention to Spin Off Alcon
Friday, June 29 2018 | 11 h 33 min | News
Novartis has announced that they intend to seek shareholder approval to spin off 100% of Alcon's eye care device business into a standalone,...
Read MoreNovartis Delivers Strong First Quarter in 2018
Friday, April 20 2018 | 12 h 32 min | Financial News, News, Press Release
Net sales for the first quarter of 2018 were CAD 161 billion, an increase of 4% at constant currencies Core operating income also grew by...
Read MoreNovartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat
Thursday, February 2 2017 | 00 h 00 min | Financial News
Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...
Read MoreNovartis on Alcon: All Options are Open
Monday, November 14 2016 | 00 h 00 min | News
Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon The source is an...
Read MoreAlcon Expands Glaucoma Treatment Portfolio by Acquiring Transcend Medical
Wednesday, February 24 2016 | 00 h 00 min | Acquisitions, Press Release
Alcon announced that it has entered into an agreement to acquire Transcend Medical, Inc, a privately-held, US-based company focused on developing...
Read More